CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption accelerates with new CPT code [Seeking Alpha]
CVRx, Inc. (CVRX)
Company Research
Source: Seeking Alpha
Kevin Hykes, President and CEO, highlighted fourth quarter revenue of $16 million and full year revenue of $56.7 million, noting "growth of 4% and 10%, respectively." Hykes described 2025 as "a year of important and necessary investment in our commercial foundation Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Management expects the new Category 1 CPT code to reduce reimbursement friction and improve prior authorization approval rates, resulting in easier and broader market access for Barostim therapy. The BENEFIT-HF trial could triple CVRx's addressable market to $30 billion, generate device sales at trial sites, enhance credibility, and drive goodwill, potentially benefiting core business growth and expansion. Adding active territories and implanting centers, with guidance anticipating steady quarterly territory growth, expanded sa
Show less
Read more
Impact Snapshot
Event Time:
CVRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVRX alerts
High impacting CVRx, Inc. news events
Weekly update
A roundup of the hottest topics
CVRX
News
- CVRx (NASDAQ:CVRX) was given a new $10.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- CVRx (CVRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRXPR Newswire
CVRX
Earnings
- 2/12/26 - Miss
CVRX
Analyst Actions
- 2/13/26 - Canaccord Genuity
CVRX
Sec Filings
- 2/13/26 - Form S-8
- 2/13/26 - Form 10-K
- 2/12/26 - Form 8-K
- CVRX's page on the SEC website